Tewari Devesh, Mocan Andrei, Parvanov Emil D, Sah Archana N, Nabavi Seyed M, Huminiecki Lukasz, Ma Zheng Feei, Lee Yeong Yeh, Horbańczuk Jarosław O, Atanasov Atanas G
Department of Pharmaceutical Sciences, Faculty of Technology, Kumaun UniversityNainital, India.
Department of Pharmaceutical Botany, "Iuliu Haţieganu" University of Medicine and PharmacyCluj-Napoca, Romania.
Front Pharmacol. 2017 Aug 10;8:519. doi: 10.3389/fphar.2017.00519. eCollection 2017.
In many developing countries, jaundice is the common symptom of hepatic diseases which are a major cause of mortality. The use of natural product-based therapies is very popular for such hepatic disorders. A great number of medicinal plants have been utilized for this purpose and some facilitated the discovery of active compounds which helped the development of new synthetic drugs against jaundice. However, more epidemiological studies and clinical trials are required for the practical implementation of the plant pharmacotherapy of jaundice. The focus of this second part of our review is on several of the most prominent plants used against jaundice identified in the analysis performed in the first part of the review viz. (Burm.f.) Nees, (L.) Gaertn., Retz., L. and some species of genus . Furthermore, we discuss their physiological effects, biologically active ingredients, and the potential mechanisms of action. Some of the most important active ingredients were silybin (also recommended by German commission), phyllanthin and andrographolide, whose action leads to bilirubin reduction and normalization of the levels of relevant serum enzymes indicative for the pathophysiological status of the liver.
在许多发展中国家,黄疸是肝脏疾病的常见症状,而肝脏疾病是主要的死亡原因。基于天然产物的疗法在这类肝脏疾病中非常流行。大量药用植物已被用于此目的,一些植物促进了活性化合物的发现,这些活性化合物有助于开发抗黄疸的新型合成药物。然而,黄疸植物药物疗法的实际应用还需要更多的流行病学研究和临床试验。我们综述第二部分的重点是在综述第一部分所进行的分析中确定的几种治疗黄疸最突出的植物,即(Burm.f.)Nees、(L.)Gaertn.、Retz.、L.以及属的一些物种。此外,我们讨论它们的生理作用、生物活性成分和潜在作用机制。一些最重要的活性成分是水飞蓟宾(德国委员会也推荐)、叶下珠素和穿心莲内酯,它们的作用导致胆红素降低以及指示肝脏病理生理状态的相关血清酶水平正常化。